In 2016, OFweek Medical Network, as the first year of the “Thirteenth Five-Year Plan”, laid a solid foundation for the steady development of all walks of life, paving the way for the future to grow stronger. Last year, China's pharmaceutical industry continued to move and policies continued. Under the promotion of medical policy reform, the development of China's pharmaceutical industry is also entering the fast lane of regulation. Medical instruments and instruments are an important part of the pharmaceutical industry and will be related to the pharmaceutical industry. Together with the golden age. According to the China Medical Industry Information Center, the domestic medical device market will exceed 600 billion yuan in 2019, and the compound annual growth rate is expected to be 16.8%, which will maintain a relatively fast growth trend.

In the entire medical device industry chain, channels (device commercial circulation links) play an important role as a link between medical device manufacturers and medical institutions at all levels. At present, medical device manufacturers in China have built corresponding marketing channels according to their own capabilities (product differentiation and channel control). The main modes used are reserve agents, high-opening, direct sales and self-operated. Because domestic and foreign medical device companies have different aspects in product positioning, promotion capabilities, management level, and compliance requirements, there are certain differences in the modes used by domestic and foreign manufacturers when they deploy channels.

At present, domestic market data on the medical device industry and other data are mostly based on industrial data, calculated from the production caliber (ex-factory price). Based on the 2015 statistics of China Medical Industry Information Center, the removal of home medical devices (main application scenarios are not covered by medical institutions at all levels, not within the scope of this article), the market space of domestic medical device channels and the terminal market capacity of medical institutions Estimate.

In 2015, there were four major medical equipment sectors: medical equipment market space of 99.4 billion yuan, high-value consumables market space of 35.9 billion yuan, low-value consumables market space of 33.1 billion yuan, IVD product market space of 44.2 billion yuan; according to industry chain research, according to The above four major plates are respectively an average of 70, 28, 55, and 45 buckles to enlarge the market space of the medical device channel link. %), the market space for domestic medical device channel links is about 427.8 billion yuan.

Cosmetic Ingredients

Cosmetics are compound mixtures made from various raw materials after reasonable blending and processing. There are many types of cosmetics raw materials with different properties. According to the raw material properties and uses of cosmetics, it can be roughly divided into two categories: base raw materials and auxiliary raw materials. The former is a main raw material of cosmetics, which occupies a large proportion in cosmetic formulations, and is the main functional substance in cosmetics. The latter is responsible for shaping, stabilizing or imparting color, fragrance and other characteristics to cosmetics. These substances are not used in large amounts in cosmetic formulations, but are extremely important. Cosmetics are chemical mixtures made of natural, synthetic or extracted substances with different functions as raw materials and processed through production processes such as heating, stirring and emulsification.

Collagen peptide, Arbutin, Coenzyme Q10, GSH, Cosmetic Raw Materials, lipoic acid

Xi'an Gawen Biotechnology Co., Ltd , https://www.ahualyn-bios.com